ARCOMA Arcoma AB (publ)

0.7874USD8.000 SEK · STO+0.25%Mkt Cap: 11.27M USDP/E: 23.53

Arcoma AB (publ) develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general…

Key Statistics

Company
Market Cap11.27M USD
Enterprise Value8.28M USD
Revenue (TTM)12.17M USD
Gross Profit5.24M USD
Net Income (TTM)495.10K USD
Revenue/Share0.85 USD
Last Price0.7874 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees31
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0006219176
Valuation
P/E (Trailing)23.53
P/E (Forward)7.02
PEG—
EV/EBITDA20.36
EV/Revenue0.68
P/S0.93
P/B1.46
EPS (TTM)0.03 USD
EPS (Forward)0.11 USD
52W Range
0.606347% of range0.9892
52W High0.9892 USD
52W Low0.6063 USD
Profitability
Gross Margin40.73%
Oper. Margin4.67%
EBITDA Margin3.34%
Profit Margin3.85%
ROE6.73%
ROA5.20%
ROIC12.62%
ROCE8.35%
Growth
Revenue Growth-12.30%
Earnings Growth45.50%
Cash Flow & Leverage
Operating CF1.84M USD
CapEx (TTM)553.57K USD
FCF Margin3.21%
FCF Yield3.47%
Net Debt-2.99M USD
Net Debt/EBITDA-7.35
Net Debt/FCF-7.65
Balance Sheet
Debt/Equity0.00
Current Ratio4.52
Quick Ratio3.12
Book Value/Sh0.54 USD
Cash/Share0.21 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.14.31M
Float11.93M
Insiders21.79%
Institutions50.90%
Technical
SMA 500.7683 (+2.5%)
SMA 2000.8043 (-2.1%)
Beta0.70
S&P 52W Chg12.00%
Avg Vol (30d)10.86K
Avg Vol (10d)8.27K
Technical Indicators
RSI (14)50.1
MACD0.0804
MACD Signal0.1337
MACD Hist.-0.0533
BB Upper0.8676 USD
BB Middle0.7974 USD
BB Lower0.7271 USD
BB Width17.62%
ATR (14)0.0398 USD
Vol Ratio (20d)0.00x

About Arcoma (STO: ARCOMA)

›

Arcoma (STO: ARCOMA) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 31 employees.

The shares were at 8.000 SEK on 19 November 2026, down 3.4% over 52 weeks. Its 52-week range is 6.160 SEK to 10.05 SEK: the price is 20.4% below the high and 29.9% above the low.

At a market capitalisation of 114.47M SEK, it trades at 23.5 times trailing earnings and 7.0 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, so ARCOMA is valued in line with them.

Arcoma reports return on equity of 6.7%, an operating margin of 4.7% and revenue down 12.3% year over year.

It holds more cash than debt, a net cash position of 30.36M SEK. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.